0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inactivated Poultry Vaccine Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-24A9332
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Inactivated Poultry Vaccine Market Research Report 2022
BUY CHAPTERS

Global Inactivated Poultry Vaccine Market Research Report 2025

Code: QYRE-Auto-24A9332
Report
February 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Inactivated Poultry Vaccine Market Size

The global market for Inactivated Poultry Vaccine was valued at US$ 3335 million in the year 2024 and is projected to reach a revised size of US$ 4519 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Inactivated Poultry Vaccine Market

Inactivated Poultry Vaccine Market

Inactivated poultry vaccines belong to a class of preventative biologics called "subunit/inactivated virus vaccines." They contain only parts of the virus rather than the entire pathogen. These components are isolated from disease cells and weakened or killed before use in humans and animals so they won"t cause illness but still trigger immune responses to protect against subsequent exposure to live viruses.
The global inactivated poultry vaccine market represents one segment within the broader animal vaccines industry that includes subcategories based on species and diseases targeted. This particular subset serves as a critical component in global efforts to manage avian influenza outbreaks caused by deadly H5N8 and H5N6 strains spreading rapidly across continents posing serious threats to human and animal health. To combat this devastating threat, governments around the globe encourage research & development (R&D) investment in effective vaccines adaptable to different regions and birds breeds while companies strive to meet escalating consumer needs driving accelerated evolution towards safer, stronger formulations guaranteeing enhanced protection versus emerging virulent strains. Ongoing studies explore advanced manufacturing techniques and adjuvants promising increased potency and longevity, expanding opportunities for market expansion beyond current offerings leveraged mainly in Asian-Pacific countries where demand remains consistently strong. Suppliers maintain competitive edge via continuous innovation refining production processes ensuring quality performance under diverse conditions extending lifespans maximizing efficiency minimizing waste amidst persistent supply chain complexities faced daily by every participant operating within volatile environments rife with unpredictability testing resilience throughout extended value chains impacting everyone along each step necessitating flexibility adaptability sustaining viability securing future success.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inactivated Poultry Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Poultry Vaccine.
The Inactivated Poultry Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Poultry Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Poultry Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Inactivated Poultry Vaccine Market Report

Report Metric Details
Report Name Inactivated Poultry Vaccine Market
Accounted market size in year US$ 3335 million
Forecasted market size in 2031 US$ 4519 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Avian Encephalomyelitis
  • Chicken Anaemia
  • Egg Drop Syndrome
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Phibro Animal Health, Virbac, Hipra, Venkys, Biovet, Ringpu Biology, Ceva Corporate, KM Biologics, Vaxxinova, Japfa Comfeed Indonesia, Nisseiken
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Inactivated Poultry Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Inactivated Poultry Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Inactivated Poultry Vaccine Market growing?

Ans: The Inactivated Poultry Vaccine Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Inactivated Poultry Vaccine Market size in 2031?

Ans: The Inactivated Poultry Vaccine Market size in 2031 will be US$ 4519 million.

Who are the main players in the Inactivated Poultry Vaccine Market report?

Ans: The main players in the Inactivated Poultry Vaccine Market are Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Phibro Animal Health, Virbac, Hipra, Venkys, Biovet, Ringpu Biology, Ceva Corporate, KM Biologics, Vaxxinova, Japfa Comfeed Indonesia, Nisseiken

What are the Application segmentation covered in the Inactivated Poultry Vaccine Market report?

Ans: The Applications covered in the Inactivated Poultry Vaccine Market report are Avian Encephalomyelitis, Chicken Anaemia, Egg Drop Syndrome, Others

What are the Type segmentation covered in the Inactivated Poultry Vaccine Market report?

Ans: The Types covered in the Inactivated Poultry Vaccine Market report are Liquid Vaccines, Freeze-Dried Vaccines

Recommended Reports

Poultry Vaccines

Livestock & Animal Vaccines

Diagnostic & Flu Vaccines

1 Inactivated Poultry Vaccine Market Overview
1.1 Product Definition
1.2 Inactivated Poultry Vaccine by Type
1.2.1 Global Inactivated Poultry Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Liquid Vaccines
1.2.3 Freeze-Dried Vaccines
1.3 Inactivated Poultry Vaccine by Application
1.3.1 Global Inactivated Poultry Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Avian Encephalomyelitis
1.3.3 Chicken Anaemia
1.3.4 Egg Drop Syndrome
1.3.5 Others
1.4 Global Inactivated Poultry Vaccine Market Size Estimates and Forecasts
1.4.1 Global Inactivated Poultry Vaccine Revenue 2020-2031
1.4.2 Global Inactivated Poultry Vaccine Sales 2020-2031
1.4.3 Global Inactivated Poultry Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inactivated Poultry Vaccine Market Competition by Manufacturers
2.1 Global Inactivated Poultry Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inactivated Poultry Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inactivated Poultry Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inactivated Poultry Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inactivated Poultry Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Poultry Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Inactivated Poultry Vaccine, Date of Enter into This Industry
2.8 Global Inactivated Poultry Vaccine Market Competitive Situation and Trends
2.8.1 Global Inactivated Poultry Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inactivated Poultry Vaccine Players Market Share by Revenue
2.8.3 Global Inactivated Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inactivated Poultry Vaccine Market Scenario by Region
3.1 Global Inactivated Poultry Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inactivated Poultry Vaccine Sales by Region: 2020-2031
3.2.1 Global Inactivated Poultry Vaccine Sales by Region: 2020-2025
3.2.2 Global Inactivated Poultry Vaccine Sales by Region: 2026-2031
3.3 Global Inactivated Poultry Vaccine Revenue by Region: 2020-2031
3.3.1 Global Inactivated Poultry Vaccine Revenue by Region: 2020-2025
3.3.2 Global Inactivated Poultry Vaccine Revenue by Region: 2026-2031
3.4 North America Inactivated Poultry Vaccine Market Facts & Figures by Country
3.4.1 North America Inactivated Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inactivated Poultry Vaccine Sales by Country (2020-2031)
3.4.3 North America Inactivated Poultry Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Inactivated Poultry Vaccine Market Facts & Figures by Country
3.5.1 Europe Inactivated Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inactivated Poultry Vaccine Sales by Country (2020-2031)
3.5.3 Europe Inactivated Poultry Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inactivated Poultry Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Inactivated Poultry Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inactivated Poultry Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Inactivated Poultry Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Inactivated Poultry Vaccine Market Facts & Figures by Country
3.7.1 Latin America Inactivated Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inactivated Poultry Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Inactivated Poultry Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Poultry Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inactivated Poultry Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inactivated Poultry Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Inactivated Poultry Vaccine Sales by Type (2020-2031)
4.1.1 Global Inactivated Poultry Vaccine Sales by Type (2020-2025)
4.1.2 Global Inactivated Poultry Vaccine Sales by Type (2026-2031)
4.1.3 Global Inactivated Poultry Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Inactivated Poultry Vaccine Revenue by Type (2020-2031)
4.2.1 Global Inactivated Poultry Vaccine Revenue by Type (2020-2025)
4.2.2 Global Inactivated Poultry Vaccine Revenue by Type (2026-2031)
4.2.3 Global Inactivated Poultry Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Inactivated Poultry Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inactivated Poultry Vaccine Sales by Application (2020-2031)
5.1.1 Global Inactivated Poultry Vaccine Sales by Application (2020-2025)
5.1.2 Global Inactivated Poultry Vaccine Sales by Application (2026-2031)
5.1.3 Global Inactivated Poultry Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Inactivated Poultry Vaccine Revenue by Application (2020-2031)
5.2.1 Global Inactivated Poultry Vaccine Revenue by Application (2020-2025)
5.2.2 Global Inactivated Poultry Vaccine Revenue by Application (2026-2031)
5.2.3 Global Inactivated Poultry Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Inactivated Poultry Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis Inactivated Poultry Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Animal Health Inactivated Poultry Vaccine Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Inactivated Poultry Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Elanco Animal Health
6.4.1 Elanco Animal Health Company Information
6.4.2 Elanco Animal Health Description and Business Overview
6.4.3 Elanco Animal Health Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Elanco Animal Health Inactivated Poultry Vaccine Product Portfolio
6.4.5 Elanco Animal Health Recent Developments/Updates
6.5 Phibro Animal Health
6.5.1 Phibro Animal Health Company Information
6.5.2 Phibro Animal Health Description and Business Overview
6.5.3 Phibro Animal Health Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Phibro Animal Health Inactivated Poultry Vaccine Product Portfolio
6.5.5 Phibro Animal Health Recent Developments/Updates
6.6 Virbac
6.6.1 Virbac Company Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Virbac Inactivated Poultry Vaccine Product Portfolio
6.6.5 Virbac Recent Developments/Updates
6.7 Hipra
6.7.1 Hipra Company Information
6.7.2 Hipra Description and Business Overview
6.7.3 Hipra Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hipra Inactivated Poultry Vaccine Product Portfolio
6.7.5 Hipra Recent Developments/Updates
6.8 Venkys
6.8.1 Venkys Company Information
6.8.2 Venkys Description and Business Overview
6.8.3 Venkys Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Venkys Inactivated Poultry Vaccine Product Portfolio
6.8.5 Venkys Recent Developments/Updates
6.9 Biovet
6.9.1 Biovet Company Information
6.9.2 Biovet Description and Business Overview
6.9.3 Biovet Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Biovet Inactivated Poultry Vaccine Product Portfolio
6.9.5 Biovet Recent Developments/Updates
6.10 Ringpu Biology
6.10.1 Ringpu Biology Company Information
6.10.2 Ringpu Biology Description and Business Overview
6.10.3 Ringpu Biology Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ringpu Biology Inactivated Poultry Vaccine Product Portfolio
6.10.5 Ringpu Biology Recent Developments/Updates
6.11 Ceva Corporate
6.11.1 Ceva Corporate Company Information
6.11.2 Ceva Corporate Description and Business Overview
6.11.3 Ceva Corporate Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Ceva Corporate Inactivated Poultry Vaccine Product Portfolio
6.11.5 Ceva Corporate Recent Developments/Updates
6.12 KM Biologics
6.12.1 KM Biologics Company Information
6.12.2 KM Biologics Description and Business Overview
6.12.3 KM Biologics Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 KM Biologics Inactivated Poultry Vaccine Product Portfolio
6.12.5 KM Biologics Recent Developments/Updates
6.13 Vaxxinova
6.13.1 Vaxxinova Company Information
6.13.2 Vaxxinova Description and Business Overview
6.13.3 Vaxxinova Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Vaxxinova Inactivated Poultry Vaccine Product Portfolio
6.13.5 Vaxxinova Recent Developments/Updates
6.14 Japfa Comfeed Indonesia
6.14.1 Japfa Comfeed Indonesia Company Information
6.14.2 Japfa Comfeed Indonesia Description and Business Overview
6.14.3 Japfa Comfeed Indonesia Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Japfa Comfeed Indonesia Inactivated Poultry Vaccine Product Portfolio
6.14.5 Japfa Comfeed Indonesia Recent Developments/Updates
6.15 Nisseiken
6.15.1 Nisseiken Company Information
6.15.2 Nisseiken Description and Business Overview
6.15.3 Nisseiken Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Nisseiken Inactivated Poultry Vaccine Product Portfolio
6.15.5 Nisseiken Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inactivated Poultry Vaccine Industry Chain Analysis
7.2 Inactivated Poultry Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Poultry Vaccine Production Mode & Process Analysis
7.4 Inactivated Poultry Vaccine Sales and Marketing
7.4.1 Inactivated Poultry Vaccine Sales Channels
7.4.2 Inactivated Poultry Vaccine Distributors
7.5 Inactivated Poultry Vaccine Customer Analysis
8 Inactivated Poultry Vaccine Market Dynamics
8.1 Inactivated Poultry Vaccine Industry Trends
8.2 Inactivated Poultry Vaccine Market Drivers
8.3 Inactivated Poultry Vaccine Market Challenges
8.4 Inactivated Poultry Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Inactivated Poultry Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Inactivated Poultry Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Inactivated Poultry Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Inactivated Poultry Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Inactivated Poultry Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Inactivated Poultry Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Inactivated Poultry Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Inactivated Poultry Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Inactivated Poultry Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Inactivated Poultry Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Inactivated Poultry Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Inactivated Poultry Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Inactivated Poultry Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Poultry Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Inactivated Poultry Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Inactivated Poultry Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Inactivated Poultry Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Inactivated Poultry Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Inactivated Poultry Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Inactivated Poultry Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Inactivated Poultry Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Inactivated Poultry Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Inactivated Poultry Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Inactivated Poultry Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Inactivated Poultry Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Inactivated Poultry Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Inactivated Poultry Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Inactivated Poultry Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Inactivated Poultry Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Inactivated Poultry Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Inactivated Poultry Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Inactivated Poultry Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Inactivated Poultry Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Inactivated Poultry Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Inactivated Poultry Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Inactivated Poultry Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Inactivated Poultry Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Inactivated Poultry Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Inactivated Poultry Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Inactivated Poultry Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Inactivated Poultry Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Inactivated Poultry Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Inactivated Poultry Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Inactivated Poultry Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Inactivated Poultry Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Inactivated Poultry Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Inactivated Poultry Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Inactivated Poultry Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Inactivated Poultry Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Inactivated Poultry Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Inactivated Poultry Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Inactivated Poultry Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Inactivated Poultry Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Inactivated Poultry Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Inactivated Poultry Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Inactivated Poultry Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Inactivated Poultry Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Inactivated Poultry Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Inactivated Poultry Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Inactivated Poultry Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Inactivated Poultry Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Inactivated Poultry Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Inactivated Poultry Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Inactivated Poultry Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Inactivated Poultry Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Inactivated Poultry Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Inactivated Poultry Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Inactivated Poultry Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Zoetis Company Information
 Table 71. Zoetis Description and Business Overview
 Table 72. Zoetis Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Zoetis Inactivated Poultry Vaccine Product
 Table 74. Zoetis Recent Developments/Updates
 Table 75. Merck Animal Health Company Information
 Table 76. Merck Animal Health Description and Business Overview
 Table 77. Merck Animal Health Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck Animal Health Inactivated Poultry Vaccine Product
 Table 79. Merck Animal Health Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim Inactivated Poultry Vaccine Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Elanco Animal Health Company Information
 Table 86. Elanco Animal Health Description and Business Overview
 Table 87. Elanco Animal Health Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Elanco Animal Health Inactivated Poultry Vaccine Product
 Table 89. Elanco Animal Health Recent Developments/Updates
 Table 90. Phibro Animal Health Company Information
 Table 91. Phibro Animal Health Description and Business Overview
 Table 92. Phibro Animal Health Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Phibro Animal Health Inactivated Poultry Vaccine Product
 Table 94. Phibro Animal Health Recent Developments/Updates
 Table 95. Virbac Company Information
 Table 96. Virbac Description and Business Overview
 Table 97. Virbac Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Virbac Inactivated Poultry Vaccine Product
 Table 99. Virbac Recent Developments/Updates
 Table 100. Hipra Company Information
 Table 101. Hipra Description and Business Overview
 Table 102. Hipra Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Hipra Inactivated Poultry Vaccine Product
 Table 104. Hipra Recent Developments/Updates
 Table 105. Venkys Company Information
 Table 106. Venkys Description and Business Overview
 Table 107. Venkys Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Venkys Inactivated Poultry Vaccine Product
 Table 109. Venkys Recent Developments/Updates
 Table 110. Biovet Company Information
 Table 111. Biovet Description and Business Overview
 Table 112. Biovet Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Biovet Inactivated Poultry Vaccine Product
 Table 114. Biovet Recent Developments/Updates
 Table 115. Ringpu Biology Company Information
 Table 116. Ringpu Biology Description and Business Overview
 Table 117. Ringpu Biology Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Ringpu Biology Inactivated Poultry Vaccine Product
 Table 119. Ringpu Biology Recent Developments/Updates
 Table 120. Ceva Corporate Company Information
 Table 121. Ceva Corporate Description and Business Overview
 Table 122. Ceva Corporate Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Ceva Corporate Inactivated Poultry Vaccine Product
 Table 124. Ceva Corporate Recent Developments/Updates
 Table 125. KM Biologics Company Information
 Table 126. KM Biologics Description and Business Overview
 Table 127. KM Biologics Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. KM Biologics Inactivated Poultry Vaccine Product
 Table 129. KM Biologics Recent Developments/Updates
 Table 130. Vaxxinova Company Information
 Table 131. Vaxxinova Description and Business Overview
 Table 132. Vaxxinova Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Vaxxinova Inactivated Poultry Vaccine Product
 Table 134. Vaxxinova Recent Developments/Updates
 Table 135. Japfa Comfeed Indonesia Company Information
 Table 136. Japfa Comfeed Indonesia Description and Business Overview
 Table 137. Japfa Comfeed Indonesia Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Japfa Comfeed Indonesia Inactivated Poultry Vaccine Product
 Table 139. Japfa Comfeed Indonesia Recent Developments/Updates
 Table 140. Nisseiken Company Information
 Table 141. Nisseiken Description and Business Overview
 Table 142. Nisseiken Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Nisseiken Inactivated Poultry Vaccine Product
 Table 144. Nisseiken Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Inactivated Poultry Vaccine Distributors List
 Table 148. Inactivated Poultry Vaccine Customers List
 Table 149. Inactivated Poultry Vaccine Market Trends
 Table 150. Inactivated Poultry Vaccine Market Drivers
 Table 151. Inactivated Poultry Vaccine Market Challenges
 Table 152. Inactivated Poultry Vaccine Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Inactivated Poultry Vaccine
 Figure 2. Global Inactivated Poultry Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Inactivated Poultry Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Liquid Vaccines Product Picture
 Figure 5. Freeze-Dried Vaccines Product Picture
 Figure 6. Global Inactivated Poultry Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Inactivated Poultry Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Avian Encephalomyelitis
 Figure 9. Chicken Anaemia
 Figure 10. Egg Drop Syndrome
 Figure 11. Others
 Figure 12. Global Inactivated Poultry Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Inactivated Poultry Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Inactivated Poultry Vaccine Sales (2020-2031) & (K Units)
 Figure 15. Global Inactivated Poultry Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 16. Inactivated Poultry Vaccine Report Years Considered
 Figure 17. Inactivated Poultry Vaccine Sales Share by Manufacturers in 2024
 Figure 18. Global Inactivated Poultry Vaccine Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Inactivated Poultry Vaccine Players: Market Share by Revenue in Inactivated Poultry Vaccine in 2024
 Figure 20. Inactivated Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Inactivated Poultry Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Inactivated Poultry Vaccine Sales Market Share by Country (2020-2031)
 Figure 23. North America Inactivated Poultry Vaccine Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Inactivated Poultry Vaccine Sales Market Share by Country (2020-2031)
 Figure 27. Europe Inactivated Poultry Vaccine Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Inactivated Poultry Vaccine Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Inactivated Poultry Vaccine Revenue Market Share by Region (2020-2031)
 Figure 35. China Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Inactivated Poultry Vaccine Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Inactivated Poultry Vaccine Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Inactivated Poultry Vaccine Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Inactivated Poultry Vaccine Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Inactivated Poultry Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Inactivated Poultry Vaccine by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Inactivated Poultry Vaccine by Type (2020-2031)
 Figure 57. Global Inactivated Poultry Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Inactivated Poultry Vaccine by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Inactivated Poultry Vaccine by Application (2020-2031)
 Figure 60. Global Inactivated Poultry Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 61. Inactivated Poultry Vaccine Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD